Spravato®

About The Treatment

SPRAVATO® is the first FDA-approved nasal spray medication, taken with an oral antidepressant, for treatment-resistant depression in adults. The approval of this drug by the FDA is considered to be one of the most significant advances in mental health in the last 30 years, as now patients who have failed two or more antidepressants have a safe, fast-acting, solution that is covered by most insurance.

MWI Health is an approved Spravato® center. Interested in learning more? Call to schedule an evaluation or click the button below to fill out our new patient forms. For our South Dakota location, please call (605) 573-2000. To reach our Iowa office, please call (515) 500-6082.

The Benefits of Spravato with MWI

Rapid Relief

Fast-acting nature of esketamine nasal spray in treating depressive symptoms make Spravato stand out from other treatments that may take weeks to achieve their full effect.

No Needles Involved

SPRAVATO is self-administered through a nasal spray with observation in a relaxed and comfortable environment.

Works Differently

Heal the root cause of depression by targeting the NMDA receptor instead of managing symptoms.

A United Care Team

Work with a multidisciplinary team of professionals who are focused on your health and well-being.

Become a Patient

Call us to book your appointment. For our South Dakota location, please call (605) 573-2000. To reach our Iowa office, please call (515) 500-6082.

Be sure to arrive 10-15 minutes early for your appointment so you can complete your usual or new documents, get your vitals taken, allow time for bathroom or UAs, etc. This will keep our providers on schedule, and we appreciate your help with this!

Contact Us

First name(Required)

Email *(Required)

Phone(Required)

Inquiry(Required)

Comments

This field is for validation purposes and should be left unchanged.